|
US4777964A
(en)
|
1986-01-02 |
1988-10-18 |
David Briggs |
System for obtaining blood samples and submitting for testing of aids
|
|
US5096830A
(en)
|
1987-11-17 |
1992-03-17 |
Adeza Biomedical Corporation |
Preterm labor and membrane rupture test
|
|
US5223440A
(en)
|
1987-11-17 |
1993-06-29 |
Adeza Biomedical Corporation |
Ex vivo product of conception test to determine abortion
|
|
US4919889A
(en)
|
1988-09-15 |
1990-04-24 |
Aspen Diagnostics Corporation |
Sample collection and transport fluid composition
|
|
US5281522A
(en)
|
1988-09-15 |
1994-01-25 |
Adeza Biomedical Corporation |
Reagents and kits for determination of fetal fibronectin in a vaginal sample
|
|
WO1993009438A1
(en)
|
1991-11-04 |
1993-05-13 |
Adeza Biomedical Corporation |
Screening method for identifying women at increased risk for preterm delivery
|
|
WO1993009432A1
(en)
|
1991-11-04 |
1993-05-13 |
Adeza Biomedical Corporation |
Screening method for identifying women at increased risk for imminent delivery
|
|
US5516702A
(en)
|
1991-11-06 |
1996-05-14 |
Adeza Biomedical Corporation |
Screening method for identifying women at increased risk for imminent delivery
|
|
WO1994019693A1
(en)
|
1993-02-24 |
1994-09-01 |
Baxter Diagnostics Inc. |
Immobilization of specific binding assay reagents
|
|
US5898005A
(en)
|
1993-02-24 |
1999-04-27 |
Dade Behring Inc. |
Rapid detection of analytes with receptors immobilized on soluble submicron particles
|
|
ATE226959T1
(de)
|
1993-03-23 |
2002-11-15 |
Victor Voroteliak |
Methode zur detektion von rissen in amniomembranen bei schwangeren säugetieren
|
|
US5431171A
(en)
|
1993-06-25 |
1995-07-11 |
The Regents Of The University Of California |
Monitoring fetal characteristics by radiotelemetric transmission
|
|
WO1995006877A1
(en)
|
1993-09-03 |
1995-03-09 |
Behringwerke Ag |
Fluorescent oxygen channeling immunoassays
|
|
US5650394A
(en)
|
1993-11-04 |
1997-07-22 |
Adeza Biomedical |
Use of urinastatin-like compounds to prevent premature delivery
|
|
US5597700A
(en)
|
1994-04-28 |
1997-01-28 |
California Research, Llc |
Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method
|
|
US5641636A
(en)
|
1994-05-20 |
1997-06-24 |
University Of Pennsylvania |
Method of predicting fetal membrane rupture based on matrix metalloproteinase-9 activity
|
|
US6140099A
(en)
|
1994-05-20 |
2000-10-31 |
The Trustees Of The University Of Pennsylvania |
Method of delaying fetal membrane rupture by inhibiting matrix metalloproteinase-9 activity
|
|
CA2211204C
(en)
|
1995-01-26 |
2003-10-07 |
Merck Frosst Canada Inc. |
Prostaglandin receptor dp
|
|
KR19990067153A
(ko)
|
1995-10-31 |
1999-08-16 |
사지게이쪼 |
프로스타글란딘 디 신타아제에 특이적인 단일클론항체
|
|
US6678669B2
(en)
|
1996-02-09 |
2004-01-13 |
Adeza Biomedical Corporation |
Method for selecting medical and biochemical diagnostic tests using neural network-related applications
|
|
US6120460A
(en)
|
1996-09-04 |
2000-09-19 |
Abreu; Marcio Marc |
Method and apparatus for signal acquisition, processing and transmission for evaluation of bodily functions
|
|
US6544193B2
(en)
|
1996-09-04 |
2003-04-08 |
Marcio Marc Abreu |
Noninvasive measurement of chemical substances
|
|
FI963989A7
(fi)
|
1996-10-04 |
1998-04-05 |
Wallac Oy |
Homogeenisiä määritysmenetelmiä, jotka perustuvat luminesenssienergiasiirtoon
|
|
US6376199B1
(en)
|
1997-03-07 |
2002-04-23 |
The Hospital For Sick Children (Hsc) |
Methods to diagnose a required regulation of trophoblast invasion
|
|
US6610480B1
(en)
|
1997-11-10 |
2003-08-26 |
Genentech, Inc. |
Treatment and diagnosis of cardiac hypertrophy
|
|
US6875567B1
(en)
|
1997-11-10 |
2005-04-05 |
Genentech, Inc. |
Method of detecting cardiac hypertrophy through probe hybridization and gene expression analysis
|
|
US20020031513A1
(en)
|
1997-11-24 |
2002-03-14 |
Shamir Leibovitz |
Method and pharmaceutical composition for inhibiting premature rapture of fetal membranes, ripening of uterine cervix and preterm labor in mammals
|
|
US6394952B1
(en)
|
1998-02-03 |
2002-05-28 |
Adeza Biomedical Corporation |
Point of care diagnostic systems
|
|
US6267722B1
(en)
|
1998-02-03 |
2001-07-31 |
Adeza Biomedical Corporation |
Point of care diagnostic systems
|
|
US6506789B2
(en)
|
1998-06-03 |
2003-01-14 |
Shionogi & Co., Ltd. |
Methods for the treatment of itching comprising administering PGD2 receptor antagonist
|
|
US6149590A
(en)
|
1998-07-22 |
2000-11-21 |
Smith; Ramada S. |
System for identifying premature rupture of membrane during pregnancy
|
|
US20010025140A1
(en)
|
1998-07-22 |
2001-09-27 |
Torok Brian A. |
System for identifying premature rupture of membrane during pregnancy
|
|
US6126597A
(en)
|
1998-07-22 |
2000-10-03 |
Smith; Ramada S. |
System for identifying premature rupture of membrane during pregnancy
|
|
US7109044B1
(en)
|
1998-09-04 |
2006-09-19 |
Maruha Corporation |
Method of detection and disease state management for renal diseases
|
|
JP2002528500A
(ja)
|
1998-10-29 |
2002-09-03 |
ボード・オヴ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム |
チアゾリジンジオン誘導体の早期分娩または授乳期間における子宮収縮を予防するための使用
|
|
JP2000249709A
(ja)
|
1999-02-26 |
2000-09-14 |
Maruha Corp |
冠血管インターベンション施行後の再狭窄の予測方法
|
|
US6126616A
(en)
|
1999-06-21 |
2000-10-03 |
Sanyal; Mrinal K. |
Collection of biological products from human accessory reproductive organs by absorbent systems
|
|
JP3486408B2
(ja)
|
1999-08-23 |
2004-01-13 |
株式会社ビー・エム・エル |
物質のヒトプロスタグランジンｄ２受容体に対する性質の同定方法
|
|
FR2809182B1
(fr)
|
2000-05-18 |
2003-08-15 |
Univ Rene Descartes |
Detection de l'il-6 pour la prevision des risques d'accouchement premature
|
|
US20010053876A1
(en)
|
2000-06-15 |
2001-12-20 |
Torok Brian A. |
System for identifying premature rupture of membrane during pregnancy
|
|
US6878522B2
(en)
|
2000-07-07 |
2005-04-12 |
Baiyong Li |
Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
|
|
JP3752219B2
(ja)
|
2000-07-21 |
2006-03-08 |
マルハ株式会社 |
痴呆性疾患の鑑別方法
|
|
US6410583B1
(en)
|
2000-07-25 |
2002-06-25 |
Merck Frosst Canada & Co. |
Cyclopentanoindoles, compositions containing such compounds and methods of treatment
|
|
US20020046054A1
(en)
|
2000-08-28 |
2002-04-18 |
Morand Patrick G. |
Use of blood and plasma donor samples and data in the drug discovery process
|
|
US7217725B2
(en)
|
2000-09-14 |
2007-05-15 |
Allergan, Inc. |
Prostaglandin D2 antagonist
|
|
EP1351985A2
(en)
|
2000-10-16 |
2003-10-15 |
Bayer Aktiengesellschaft |
Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
|
|
US7635571B2
(en)
|
2000-12-07 |
2009-12-22 |
Siemens Healthcare Diagnostics Products Gmbh |
Amplified signal in binding assays
|
|
JP4279561B2
(ja)
|
2001-05-23 |
2009-06-17 |
メルク フロスト カナダ リミテツド |
プロスタグランジンＤ２受容体拮抗薬としてのジヒドロピロロ［１，２−ａ］インドールおよびテトラヒドロピリド［１，２−ａ］−インドール誘導体
|
|
WO2003008978A2
(en)
|
2001-07-18 |
2003-01-30 |
Merck Frosst Canada & Co. |
Eosinophil prostaglandin d2 receptor assays
|
|
US20040197834A1
(en)
|
2001-07-20 |
2004-10-07 |
Francois Gervais |
Method to increase expression of pgd2 receptors and assays for identifying modulators of prostaglandin d2 receptors
|
|
US20050101841A9
(en)
|
2001-12-04 |
2005-05-12 |
Kimberly-Clark Worldwide, Inc. |
Healthcare networks with biosensors
|
|
AU2003247667A1
(en)
|
2002-07-01 |
2004-01-19 |
University Of Rochester Medical Center |
Method for determination of likelihood of occurrence of preterm labor in pregnant females
|
|
ES2534926T3
(es)
|
2002-07-19 |
2015-04-30 |
Beth Israel Deaconess Medical Center |
Métodos para tratar la preeclampsia
|
|
US7435419B2
(en)
|
2002-07-19 |
2008-10-14 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing and treating pre-eclampsia or eclampsia
|
|
EP2204654B1
(en)
|
2002-08-13 |
2012-12-12 |
N-Dia, Inc. |
Use of devices and methods for detecting amniotic fluid in vaginal secretions
|
|
WO2004021012A2
(en)
|
2002-08-29 |
2004-03-11 |
Diagnostic Technologies Ltd. |
Method of diagnosis of pregnancy-related complications
|
|
WO2004030674A1
(ja)
|
2002-09-30 |
2004-04-15 |
Shionogi & Co., Ltd. |
プロスタグランジンｄ２、プロスタグランジンｄ２アゴニストおよびプロスタグランジンｄ２アンタゴニストの新規用途
|
|
WO2004037206A2
(en)
|
2002-10-23 |
2004-05-06 |
University Of Hawaii |
Methods for diagnosing and treating pre-term labor
|
|
US20040100376A1
(en)
|
2002-11-26 |
2004-05-27 |
Kimberly-Clark Worldwide, Inc. |
Healthcare monitoring system
|
|
AU2003290773A1
(en)
|
2003-02-05 |
2004-09-06 |
Ciphergen Biosystems, Inc. |
Non-invasive assessment of intra-amniotic environment
|
|
US20040266025A1
(en)
|
2003-02-06 |
2004-12-30 |
Durlin Hickok |
Screening and treatment methods for prevention of preterm delivery
|
|
US8068990B2
(en)
|
2003-03-25 |
2011-11-29 |
Hologic, Inc. |
Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
|
|
US7191068B2
(en)
|
2003-03-25 |
2007-03-13 |
Proteogenix, Inc. |
Proteomic analysis of biological fluids
|
|
US8003765B2
(en)
|
2003-04-09 |
2011-08-23 |
Stony Brook Anaesthesiology, University Faculty Practice Corporation |
Methods, antibodies and kits for detecting cerebrospinal fluid in a sample
|
|
US20040203079A1
(en)
|
2003-04-09 |
2004-10-14 |
Research Foundation Of The State University Of New York |
Methods and kits for detecting cerebrospinal fluid in a sample
|
|
US20070003992A1
(en)
|
2003-04-09 |
2007-01-04 |
Pentyala Srinivas N |
Methods and kits for detecting cerebrospinal fluid in a sample
|
|
US8060195B2
(en)
|
2003-05-02 |
2011-11-15 |
The Johns Hopkins University |
Devices, systems and methods for bioimpedance measurement of cervical tissue and methods for diagnosis and treatment of human cervix
|
|
AU2004240705A1
(en)
|
2003-05-20 |
2004-12-02 |
Merck Frosst Canada & Co. |
Fluoro-methanesulfonyl-substituted cycloalkanoindoles and their use as prostaglandin D2 antagonists
|
|
WO2005007223A2
(en)
|
2003-07-16 |
2005-01-27 |
Sasha John |
Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations
|
|
JP3897117B2
(ja)
|
2003-09-24 |
2007-03-22 |
マルハ株式会社 |
妊娠中毒症の重症度判定と予知方法、および妊娠中毒症における胎児・胎盤機能の評価方法
|
|
WO2005031360A1
(ja)
|
2003-09-26 |
2005-04-07 |
Maruha Corporation |
関節リウマチの検出又は鑑別方法及び病期又は機能障害度の判別方法
|
|
US20050131287A1
(en)
|
2003-12-16 |
2005-06-16 |
Kimberly-Clark Worldwide, Inc. |
Detection of premature rupture of the amniotic membrane
|
|
DK2299275T3
(en)
|
2004-07-30 |
2018-05-07 |
Adeza Biomedical Corp |
Classification of oncofetal fetronectin level for pregnancy-related indications
|
|
US20080090759A1
(en)
|
2004-08-30 |
2008-04-17 |
Robert Kokenyesi |
Methods and kits for predicting risk for preterm labor
|
|
US20080254479A1
(en)
|
2004-08-30 |
2008-10-16 |
Cervimark, Llc |
Methods and Kits For Predicting Risk For Preterm Labor
|
|
SG155257A1
(en)
|
2004-09-24 |
2009-09-30 |
Beth Israel Hospital |
Methods of diagnosing and treating complications of pregnancy
|
|
GB0422057D0
(en)
|
2004-10-05 |
2004-11-03 |
Astrazeneca Ab |
Novel compounds
|
|
HN2005000795A
(es)
|
2004-10-15 |
2010-08-19 |
Aventis Pharma Inc |
Pirimidinas como antagonistas del receptor de prostaglandina d2
|
|
EP1839056B1
(en)
|
2004-12-21 |
2011-08-03 |
Yale University |
Diagnosis of preeclampsia
|
|
US20060166242A1
(en)
|
2005-01-06 |
2006-07-27 |
Mount Sinai Hospital |
Markers of pre-term labor
|
|
DOP2006000016A
(es)
|
2005-01-26 |
2006-07-31 |
Aventis Pharma Inc |
2-fenil-indoles como antagonistas del receptor de la prostaglandina d2.
|
|
GB0505048D0
(en)
|
2005-03-11 |
2005-04-20 |
Oxagen Ltd |
Compounds with PGD antagonist activity
|
|
AU2006226891A1
(en)
*
|
2005-03-24 |
2006-09-28 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
|
|
AU2006268140A1
(en)
|
2005-07-13 |
2007-01-18 |
Expressive Constructs, Inc. |
Substrates, sensors, and methods for assessing conditions in females
|
|
JP5064219B2
(ja)
|
2005-07-22 |
2012-10-31 |
塩野義製薬株式会社 |
Ｐｇｄ２受容体アンタゴニスト活性を有するアザインドール酸誘導体
|
|
WO2007030890A1
(en)
|
2005-09-15 |
2007-03-22 |
Bio Source (Wuhan) Technology Ltd |
A marker for prolonged rupture of membranes
|
|
GT200600457A
(es)
|
2005-10-13 |
2007-04-27 |
Aventis Pharma Inc |
Sal de fosfato dihidrogeno como antagonistas del receptor de prostaglandina d2
|
|
US8076315B2
(en)
|
2005-10-14 |
2011-12-13 |
The Board Of Trustees Of The University Of Illinois |
Pharmacological treatments for sleep disorders (apnoe) with prostanoid receptor antagonists
|
|
US20070111326A1
(en)
|
2005-11-14 |
2007-05-17 |
Abbott Laboratories |
Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia
|
|
US20080009552A1
(en)
|
2006-03-23 |
2008-01-10 |
Craig Pennell |
Markers of pre-term labor
|
|
DOP2007000068A
(es)
|
2006-04-12 |
2007-10-31 |
Sanofi Aventis Us Llc |
Compuestos de amino-pirimidina 2,6-sustituidos-4-monosustituidos como antagonistas del receptor de prostaglandina d2
|
|
EP2037967B1
(en)
|
2006-06-16 |
2016-12-07 |
The Trustees Of The University Of Pennsylvania |
Prostaglandin d2 receptor antagonists for treating androgenetic alopecia
|
|
JP2009544721A
(ja)
|
2006-07-25 |
2009-12-17 |
サノフィ−アベンティス |
プロスタグランジンｄ２受容体アンタゴニストとしての２−フェニルインドール類
|
|
US8133859B2
(en)
|
2006-09-27 |
2012-03-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
SCGB3A2 as a growth factor and anti-apoptotic agent
|
|
DK2083863T3
(da)
|
2006-10-03 |
2015-06-22 |
Genzyme Corp |
Antistoffer mod tgf-beta til anvendelse til behandling af spædbørn med risiko for udvikling af bronkopulmonal dysplasi
|
|
WO2008073491A1
(en)
|
2006-12-11 |
2008-06-19 |
University Of Florida Research Foundation, Inc. |
System and method for analyzing progress of labor and preterm labor
|
|
EP2129660A2
(en)
|
2006-12-19 |
2009-12-09 |
Pfizer Products Inc. |
Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
|
|
CA2673946C
(en)
|
2006-12-26 |
2014-10-14 |
Brigham Young University |
Serum proteomics system and associated methods
|
|
JP2010519328A
(ja)
|
2007-02-26 |
2010-06-03 |
ファイザー・プロダクツ・インク |
Ｈ−ｐｇｄｓの阻害剤としてのニコチンアミド誘導体およびプロスタグランジンｄ２が媒介する疾患の治療のためのそれらの使用
|
|
US20090058072A1
(en)
|
2007-08-30 |
2009-03-05 |
Shirlee Ann Weber |
Record sheets with integrated themes
|
|
WO2009039476A1
(en)
|
2007-09-20 |
2009-03-26 |
Johns Hopkins University |
Treatment and prevention of ischemic brain injury
|
|
US20110002866A1
(en)
|
2007-10-31 |
2011-01-06 |
Lubit Beverly W |
Methods to prevent a hair-related side effect of treatment with a chemotherapeutic agent
|
|
WO2009059259A2
(en)
|
2007-10-31 |
2009-05-07 |
Children's Hospital Medical Center |
Detection of worsening renal disease in subjects with systemic lupus erythematosus
|
|
WO2009061681A2
(en)
|
2007-11-06 |
2009-05-14 |
Amira Pharmaceuticals, Inc |
Antagonists of pgd2 receptors
|
|
US20110065139A1
(en)
|
2007-11-27 |
2011-03-17 |
Jacob Mullerad |
diagnostic device for identifying rupture of membrane during pregnancy
|
|
US20130177485A1
(en)
|
2007-11-27 |
2013-07-11 |
Momtec Life Ltd. Of Yazmot Haemek |
Diagnostic device for identifying rupture of membrane during pregnancy
|
|
PT2229358E
(pt)
|
2007-12-14 |
2011-06-29 |
Pulmagen Therapeutics Asthma Ltd |
Indoles e sua utilização terapêutica
|
|
WO2009089286A1
(en)
|
2008-01-07 |
2009-07-16 |
Ortho-Clinical Diagnostics, Inc. |
Determination of sflt-1:angiogenic factor complex
|
|
JP2011509985A
(ja)
|
2008-01-18 |
2011-03-31 |
プルマジェン セラピューティクス （アズマ） リミテッド |
Ｃｒｔｈ２受容体に対して活性なインドール
|
|
ES2587077T3
(es)
|
2008-01-25 |
2016-10-20 |
Wallac Oy |
Métodos para determinar el riesgo de anomalías cromosómicas en un feto
|
|
WO2009097584A1
(en)
|
2008-01-30 |
2009-08-06 |
Proteogenix, Inc. |
Maternal serum biomarkers for detection of pre-eclampsia
|
|
WO2009097579A1
(en)
|
2008-01-30 |
2009-08-06 |
Proteogenix, Inc. |
Gestational age dependent proteomic changes of human maternal serum for monitoring maternal and fetal health
|
|
UA98839C2
(en)
|
2008-02-01 |
2012-06-25 |
Панмира Фармасьютикалз, Ллк. |
N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
|
|
CN101952244B
(zh)
|
2008-02-01 |
2014-11-05 |
潘米拉制药公司 |
前列腺素d2受体的n，n-二取代氨基烷基联苯拮抗剂
|
|
EP2257536A4
(en)
|
2008-02-14 |
2011-03-23 |
Amira Pharmaceuticals Inc |
CYCLIC DIARYL ETHERS AS ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
|
|
JP2011513242A
(ja)
|
2008-02-25 |
2011-04-28 |
アミラ ファーマシューティカルズ，インク． |
プロスタグランジンｄ２受容体アンタゴニスト
|
|
WO2009145989A2
(en)
|
2008-04-02 |
2009-12-03 |
Amira Pharmaceuticals, Inc. |
Aminoalkylphenyl antagonists of prostaglandin d2 receptors
|
|
US20110112134A1
(en)
|
2008-05-16 |
2011-05-12 |
Amira Pharmaceuticals, Inc. |
Tricyclic Antagonists of Prostaglandin D2 Receptors
|
|
PT2288367E
(pt)
|
2008-05-16 |
2016-02-09 |
Corthera Inc |
Relaxina h2 para utilização no tratamento da dilatação cervical prematura
|
|
US8501959B2
(en)
|
2008-06-24 |
2013-08-06 |
Panmira Pharmaceuticals, Llc |
Cycloalkane[B]indole antagonists of prostaglandin D2 receptors
|
|
EP2307362A4
(en)
|
2008-07-03 |
2012-05-09 |
Panmira Pharmaceuticals Llc |
ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
|
|
FR2934681B1
(fr)
|
2008-07-29 |
2011-09-30 |
Bastien Karkouche |
Dispositif pour la capture de particules biologiques et utilisation.
|
|
CA2735525A1
(en)
|
2008-08-04 |
2010-02-11 |
The Board Of Regents Of The University Of Texas System |
Multiplexed diagnostic test for preterm labor
|
|
US8536185B2
(en)
|
2008-09-22 |
2013-09-17 |
Cayman Chemical Company, Incorporated |
Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases
|
|
GB2463788B
(en)
|
2008-09-29 |
2010-12-15 |
Amira Pharmaceuticals Inc |
Heteroaryl antagonists of prostaglandin D2 receptors
|
|
WO2010039977A2
(en)
|
2008-10-01 |
2010-04-08 |
Amira Pharmaceuticals, Inc. |
Heteroaryl antagonists of prostaglandin d2 receptors
|
|
US8524748B2
(en)
|
2008-10-08 |
2013-09-03 |
Panmira Pharmaceuticals, Llc |
Heteroalkyl biphenyl antagonists of prostaglandin D2 receptors
|
|
GB2465062B
(en)
|
2008-11-06 |
2011-04-13 |
Amira Pharmaceuticals Inc |
Cycloalkane(B)azaindole antagonists of prostaglandin D2 receptors
|
|
US8383654B2
(en)
|
2008-11-17 |
2013-02-26 |
Panmira Pharmaceuticals, Llc |
Heterocyclic antagonists of prostaglandin D2 receptors
|
|
US9180114B2
(en)
|
2008-11-26 |
2015-11-10 |
President And Fellows Of Harvard College |
Neurodegenerative diseases and methods of modeling
|
|
US20120004233A1
(en)
|
2009-01-26 |
2012-01-05 |
Amira Pharmaceuticals, Inc |
Tricyclic compounds as antagonists of prostaglandin d2 receptors
|
|
US20120046261A1
(en)
|
2009-02-27 |
2012-02-23 |
University Of Utah Research Foundation |
Compositions and methods for diagnosing and preventing spontaneous preterm birth
|
|
GB0905964D0
(en)
|
2009-04-06 |
2009-05-20 |
King S College London |
Marker
|
|
CN102596902A
(zh)
|
2009-08-05 |
2012-07-18 |
潘米拉制药公司 |
Dp2拮抗剂及其用途
|
|
US20110090048A1
(en)
|
2009-09-29 |
2011-04-21 |
Li Conan K |
Data Transmission Device with User Identification Capability
|
|
CA2779270A1
(en)
|
2009-10-29 |
2011-05-05 |
The Trustees Of The University Of Pennsylvania |
Method of predicting risk of preterm birth
|
|
WO2011060138A2
(en)
|
2009-11-12 |
2011-05-19 |
Cervilenz Inc. |
Devices and methods for cervix measurement
|
|
CN102667486B
(zh)
|
2009-11-25 |
2016-03-09 |
霍洛吉克股份有限公司 |
羊膜内感染的检测
|
|
CA2807050C
(en)
|
2009-12-08 |
2019-06-18 |
Ozlem Equils |
Diagnostic biomarker to identify women at risk for preterm delivery
|
|
US8874183B2
(en)
|
2010-02-18 |
2014-10-28 |
The Johns Hopkins University |
Preterm labor monitor
|
|
RU2012143978A
(ru)
|
2010-03-16 |
2014-04-27 |
Авентис Фармасьютикалз Инк. |
Замещенный пиримидин в качестве антагониста рецептора простагландина d2
|
|
MX2012010035A
(es)
|
2010-03-16 |
2012-10-01 |
Aventis Pharma Inc |
Pirimidinas sustituidas como antagonistas del receptor de la prostaglandina d2.
|
|
PT2558447E
(pt)
|
2010-03-22 |
2014-11-25 |
Actelion Pharmaceuticals Ltd |
Derivados de 3-(heteroarilamino)-1,2,3,4-tetrahidro-9hcarbazol e o seu uso como moduladores do receptor de prostaglandina d2
|
|
WO2011119757A2
(en)
|
2010-03-23 |
2011-09-29 |
The Reproductive Research Technologies, Lp |
Noninvasive measurement of uterine emg propagation and power spectrum frequency to predict true preterm labor and delivery
|
|
EP2558868A2
(en)
*
|
2010-04-13 |
2013-02-20 |
Pronota NV |
Biomarkers for hypertensive disorders of pregnancy
|
|
AU2011252954B2
(en)
*
|
2010-05-14 |
2015-04-16 |
Beth Israel Deaconess Medical Center |
Extracorporeal devices and methods of treating complications of pregnancy
|
|
US20110312928A1
(en)
|
2010-06-18 |
2011-12-22 |
Lipocine Inc. |
Progesterone Containing Oral Dosage Forms and Related Methods
|
|
US20110312927A1
(en)
|
2010-06-18 |
2011-12-22 |
Satish Kumar Nachaegari |
Progesterone Containing Oral Dosage Forms and Related Methods
|
|
US20110318308A1
(en)
|
2010-06-25 |
2011-12-29 |
Winthrop-University Hospital |
Lipocalin-type prostaglandin d2 synthase as a biomarker for lung cancer progression and prognosis
|
|
EP2590944B1
(en)
|
2010-07-05 |
2015-09-30 |
Actelion Pharmaceuticals Ltd. |
1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators
|
|
AP2013006667A0
(en)
|
2010-07-12 |
2013-01-31 |
Therasyn Sensors Inc |
A device and methods for in vivo monitoring of an individual
|
|
US8765487B2
(en)
|
2010-09-01 |
2014-07-01 |
Clinical Innovations |
Detection of amniotic fluid in vaginal secretions of pregnant women due to premature rupture of fetal membranes
|
|
US8647888B2
(en)
|
2010-10-01 |
2014-02-11 |
Hologic, Inc. |
Immunoassay test strip for use in a diagnostic system
|
|
EP2627781B1
(en)
|
2010-10-15 |
2017-02-22 |
Olink Bioscience AB |
Dynamic range methods
|
|
US20120142559A1
(en)
|
2010-12-06 |
2012-06-07 |
Pronota N.V. |
Biomarkers and parameters for hypertensive disorders of pregnancy
|
|
GB201101621D0
(en)
|
2011-01-31 |
2011-03-16 |
Olink Ab |
Method and product
|
|
US20120196285A1
(en)
|
2011-01-31 |
2012-08-02 |
Esoterix Genetic Laboratories, Llc |
Methods for Enriching Microparticles or Nucleic Acids Using Binding Molecules
|
|
US8951996B2
(en)
|
2011-07-28 |
2015-02-10 |
Lipocine Inc. |
17-hydroxyprogesterone ester-containing oral compositions and related methods
|
|
ES2650263T3
(es)
*
|
2011-11-09 |
2018-01-17 |
F. Hoffmann-La Roche Ag |
Dinámica de la razón de SFLT-1 o endoglina/PLGF como indicador para preeclampsia inminente y/o síndrome de HELLP
|
|
AU2013218753A1
(en)
|
2012-02-06 |
2014-09-25 |
Perkinelmer Biosignal, Inc. |
Dual-acceptor time-resolved-fret
|
|
EP2847354A4
(en)
|
2012-05-08 |
2015-12-30 |
Univ Leland Stanford Junior |
METHOD AND COMPOSITIONS FOR ASSESSING A PRE-DECLAMPSY
|
|
WO2014001244A1
(en)
|
2012-06-27 |
2014-01-03 |
Roche Diagnostics Gmbh |
MEANS AND METHODS APPLYING sFlt-1/PlGF OR ENDOGLIN/PlGF RATIO TO RULE-OUT ONSET OF PREECLAMPSIA WITHIN A CERTAIN TIME PERIOD
|
|
EP2890816B1
(en)
|
2012-08-30 |
2019-06-05 |
Ansh Labs LLC |
Papp-a2 as a marker for monitoring, predicting and diagnosing preeclampsia
|
|
ES2690782T3
(es)
|
2012-10-24 |
2018-11-22 |
Nyu Winthrop Hospital |
Biomarcador no invasivo para identificar sujetos en riesgo de parto prematuro
|
|
WO2014078622A1
(en)
*
|
2012-11-15 |
2014-05-22 |
The Brigham And Women's Hospital, Inc. |
Method and system for diagnosing and treating preeclampsia
|
|
EP2965088B1
(en)
*
|
2013-03-04 |
2018-12-05 |
IQ Products B.V. |
Prognostic marker to determine the risk for early-onset preeclampsia
|
|
CN105917232B
(zh)
*
|
2013-12-03 |
2020-10-16 |
塞尚公司 |
用于选择性确定胎盘生长因子2的方法
|
|
EP3097422B1
(en)
|
2014-01-24 |
2018-07-11 |
Roche Diagnostics GmbH |
Prediction of postpartum hellp syndrome, postpartum eclampsia or postpartum preeclampsia
|
|
WO2015148989A1
(en)
|
2014-03-27 |
2015-10-01 |
Wayne State University |
Systems and methods to identify and treat subjects at risk for obstetrical complications
|
|
MA40325A
(fr)
|
2014-07-30 |
2016-02-04 |
Matthew Cooper |
Procédés et compositions pour diagnostiquer, pronostiquer et confirmer une pré-éclampsie.
|
|
US10357469B2
(en)
|
2015-02-18 |
2019-07-23 |
Aston University |
Diagnostic assay and treatment for preeclampsia
|
|
WO2016134324A1
(en)
|
2015-02-20 |
2016-08-25 |
Neoteryx, Llc |
Method and apparatus for acquiring blood for testing
|
|
WO2016149759A1
(en)
|
2015-03-23 |
2016-09-29 |
Adelaide Research & Innovation Pty Ltd |
Methods and systems for determining risk of a pregnancy complication occurring
|
|
EP3502705B1
(en)
|
2015-09-11 |
2020-09-09 |
Universidad de los Andes |
In vitro method for identifying a pregnancy related disease
|
|
NL2016967B1
(en)
|
2016-06-15 |
2017-12-21 |
Iq Products B V |
Markers and their ratio to determine the risk for early-onset preeclampsia.
|
|
US20190353667A1
(en)
|
2017-02-06 |
2019-11-21 |
Astute Medical, Inc. |
Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure
|
|
US20190079097A1
(en)
|
2017-09-13 |
2019-03-14 |
Progenity, Inc. |
Preeclampsia biomarkers and related systems and methods
|
|
US20200264188A1
(en)
|
2017-09-13 |
2020-08-20 |
Progenity, Inc. |
Preeclampsia biomarkers and related systems and methods
|